Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis
- PMID: 25043373
- DOI: 10.1002/ijc.29084
Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis
Abstract
The prospective evidence for the associations of gamma glutamyltransferase (GGT) and alanine aminotransferase (ALT) with risk of cancer in the general population is uncertain. We conducted a systematic review and meta-analysis of published prospective observational studies evaluating the associations of baseline levels of GGT and ALT with risk of overall (incidence and/or mortality) and site-specific cancers. Relevant studies were identified in a literature search of MEDLINE, EMBASE, Web of Science, reference lists of relevant studies to April 2014 and email contact with investigators. Study specific relative risks (RRs) were meta-analyzed using random effects models. Fourteen cohort studies with data on 1.79 million participants and 57,534 cancer outcomes were included. Comparing top versus bottom thirds of baseline circulating GGT levels, pooled RRs (95% confidence intervals) were 1.32 (1.15-1.52) for overall cancer, 1.09 (0.95-1.24) for cancers of the breast and female genital organs, 1.09 (1.02-1.16) for cancers of male genital organs, 1.94 (1.35-2.79) for cancers of digestive organs and 1.33 (0.94-1.89) for cancers of respiratory and intrathoracic organs. For ALT, corresponding RRs for overall cancer were 0.96 (0.94-0.99) and 1.65 (1.52-1.79) in European and Asian populations, respectively. There was an increased risk of cancers of the digestive organs 2.44 (1.23-4.84). The pooled RR for overall cancer per 5 U/L increment in GGT levels was 1.04 (1.03-1.05). Available observational data indicate a positive log-linear association of GGT levels with overall cancer risk. The positive association was generally evident for site-specific cancers. There are geographical variations in the association of ALT and overall cancer.
Keywords: alanine aminotransferase; cancer; gamma glutamyltransferase; meta-analysis.
© 2014 UICC.
Similar articles
-
Liver Enzymes and the Risk of Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies.Genet Test Mol Biomarkers. 2019 Dec;23(12):865-870. doi: 10.1089/gtmb.2019.0142. Genet Test Mol Biomarkers. 2019. PMID: 31821094
-
Gamma-glutamyltransferase and risk of hypertension: a systematic review and dose-response meta-analysis of prospective evidence.J Hypertens. 2015 Dec;33(12):2373-81. doi: 10.1097/HJH.0000000000000763. J Hypertens. 2015. PMID: 26485462 Review.
-
Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.Atherosclerosis. 2014 Sep;236(1):7-17. doi: 10.1016/j.atherosclerosis.2014.06.006. Epub 2014 Jun 23. Atherosclerosis. 2014. PMID: 24998934 Review.
-
Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis.Int J Epidemiol. 2014 Feb;43(1):187-201. doi: 10.1093/ije/dyt192. Int J Epidemiol. 2014. PMID: 24585856 Review.
-
Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women.Int J Cancer. 2008 Oct 15;123(8):1902-6. doi: 10.1002/ijc.23714. Int J Cancer. 2008. PMID: 18688855
Cited by
-
The predictive value of γ-glutamyl transferase to serum albumin ratio in hepatocellular carcinoma patients after liver transplantation.Front Med (Lausanne). 2024 May 10;11:1380750. doi: 10.3389/fmed.2024.1380750. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38799149 Free PMC article.
-
Gamma-glutamyl transferase and the risk of all-cause and disease-specific mortality in patients with diabetes: A nationwide cohort study.J Diabetes. 2024 May;16(5):e13551. doi: 10.1111/1753-0407.13551. J Diabetes. 2024. PMID: 38664890 Free PMC article.
-
Association between serum γ-glutamyl transferase and advanced colorectal adenoma among inpatients: a case-control study.Front Oncol. 2024 Jan 12;13:1188017. doi: 10.3389/fonc.2023.1188017. eCollection 2023. Front Oncol. 2024. PMID: 38282678 Free PMC article.
-
The Effects of Second Primary Malignancies and Frailty on Overall Survival and Mortality in Geriatric Turkish Patients with Multiple Myeloma.Curr Oncol. 2023 Jun 9;30(6):5615-5630. doi: 10.3390/curroncol30060423. Curr Oncol. 2023. PMID: 37366906 Free PMC article.
-
A γ-Glutamyl Transpeptidase (GGT)-Triggered Charge Reversal Drug-Delivery System for Cervical Cancer Treatment: In Vitro and In Vivo Investigation.Pharmaceutics. 2023 Apr 25;15(5):1335. doi: 10.3390/pharmaceutics15051335. Pharmaceutics. 2023. PMID: 37242579 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous